| Year |
Citation |
Score |
| 2023 |
Clark AG, Bertrand FE, Sigounas G. A potential requirement for Smad3 phosphorylation in Notch-mediated EMT in colon cancer. Advances in Biological Regulation. 88: 100957. PMID 36739740 DOI: 10.1016/j.jbior.2023.100957 |
0.312 |
|
| 2020 |
Bertrand FE. The cross-talk of NOTCH and GSK-3 signaling in colon and other cancers. Biochimica Et Biophysica Acta. Molecular Cell Research. 118738. PMID 32389646 DOI: 10.1016/J.Bbamcr.2020.118738 |
0.373 |
|
| 2017 |
Sigounas G, Bertrand FE, Weidner DA, Vinson KE, Clark AG, Khan A. Abstract 856: Notch-1 promotes a mesenchymal phenotype in colon cancer cells via Notch-3 and Smad-3 activation Cancer Research. 77: 856-856. DOI: 10.1158/1538-7445.Am2017-856 |
0.386 |
|
| 2015 |
Vinson KE, George DC, Fender AW, Bertrand FE, Sigounas G. The Notch pathway in colorectal cancer. International Journal of Cancer. Journal International Du Cancer. PMID 26264352 DOI: 10.1002/Ijc.29800 |
0.335 |
|
| 2015 |
Fender AW, Nutter JM, Fitzgerald TL, Bertrand FE, Sigounas G. Notch-1 promotes stemness and epithelial to mesenchymal transition in colorectal cancer. Journal of Cellular Biochemistry. 116: 2517-27. PMID 25914224 DOI: 10.1002/Jcb.25196 |
0.446 |
|
| 2014 |
Bertrand FE, McCubrey JA, Angus CW, Nutter JM, Sigounas G. NOTCH and PTEN in prostate cancer. Advances in Biological Regulation. 56: 51-65. PMID 24933481 DOI: 10.1016/J.Jbior.2014.05.002 |
0.416 |
|
| 2014 |
McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 5: 2881-911. PMID 24931005 DOI: 10.18632/Oncotarget.2037 |
0.37 |
|
| 2014 |
McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Cocco L, Cervello M, Martelli AM. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia. 28: 15-33. PMID 23778311 DOI: 10.1038/Leu.2013.184 |
0.408 |
|
| 2014 |
Fender A, Nutter M, Fitzgerald T, Bertrand F, Sigounas G. Abstract 1952: Notch-1 regulated stemness and EMT in colorectal cancer Cancer Research. 74: 1952-1952. DOI: 10.1158/1538-7445.Am2014-1952 |
0.446 |
|
| 2014 |
Nutter JM, Angus CW, Bertrand FE. Abstract 1566: Notch-1 regulation of the PTEN - mTOR axis in prostate Cancer Research. 74: 1566-1566. DOI: 10.1158/1538-7445.Am2014-1566 |
0.495 |
|
| 2012 |
Bertrand FE, Angus CW, Partis WJ, Sigounas G. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle (Georgetown, Tex.). 11: 4344-51. PMID 23032367 DOI: 10.4161/Cc.22134 |
0.382 |
|
| 2011 |
Angus CW, Willis DF, Salvador WD, Bertrand FE. Abstract 497: Loss of Notch-1 expression in human prostate epithelial cells results in reduced PTEN expression and altered differentiative capacity Cancer Research. 71: 497-497. DOI: 10.1158/1538-7445.Am2011-497 |
0.538 |
|
| 2009 |
Whelan JT, Kellogg A, Shewchuk BM, Hewan-Lowe K, Bertrand FE. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression. Journal of Cellular Biochemistry. 107: 992-1001. PMID 19479935 DOI: 10.1002/Jcb.22199 |
0.732 |
|
| 2009 |
Misaghian N, Ligresti G, Steelman LS, Bertrand FE, Bäsecke J, Libra M, Nicoletti F, Stivala F, Milella M, Tafuri A, Cervello M, Martelli AM, McCubrey JA. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia. 23: 25-42. PMID 18800146 DOI: 10.1038/Leu.2008.246 |
0.382 |
|
| 2008 |
Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli AM, McCubrey JA. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia. 22: 686-707. PMID 18337767 DOI: 10.1038/Leu.2008.26 |
0.735 |
|
| 2008 |
McCubrey JA, Steelman LS, Abrams SL, Bertrand FE, Ludwig DE, Bäsecke J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli AM. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia. 22: 708-22. PMID 18337766 DOI: 10.1038/Leu.2008.27 |
0.424 |
|
| 2008 |
Whelan JT, Ludwig DL, Bertrand FE. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia. 22: 1161-9. PMID 18337761 DOI: 10.1038/Leu.2008.57 |
0.753 |
|
| 2007 |
Whelan JT, Forbes SL, Bertrand FE. CBF-1 (RBP-J kappa) binds to the PTEN promoter and regulates PTEN gene expression. Cell Cycle (Georgetown, Tex.). 6: 80-4. PMID 17245125 DOI: 10.4161/Cc.6.1.3648 |
0.754 |
|
| 2007 |
Whelan JT, Ludwig DL, Bertrand FE. HoxA9 Induces Insulin-Like Growth Factor-1 Receptor (IGF-1R) Expression in Acute Leukemia. Blood. 110: 3343-3343. DOI: 10.1182/Blood.V110.11.3343.3343 |
0.753 |
|
| 2007 |
McCubrey JA, Bertrand FE, Steelman LS, Chang F, Terrian DM, Franklin RA. Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance Apoptosis, Cell Signaling, and Human Diseases. 2: 101-134. DOI: 10.1007/978-1-59745-199-4_5 |
0.342 |
|
| 2006 |
Basecke J, Whelan JT, Griesinger F, Bertrand FE. The MLL partial tandem duplication in acute myeloid leukaemia. British Journal of Haematology. 135: 438-49. PMID 16965385 DOI: 10.1111/J.1365-2141.2006.06301.X |
0.701 |
|
| 2006 |
McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Advances in Enzyme Regulation. 46: 249-279. PMID 16854453 DOI: 10.1016/J.Advenzreg.2006.01.004 |
0.488 |
|
| 2006 |
Bertrand FE, Steelman LS, Chappell WH, Abrams SL, Shelton JG, White ER, Ludwig DL, McCubrey JA. Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells. Leukemia. 20: 1254-60. PMID 16642049 DOI: 10.1038/Sj.Leu.2404217 |
0.402 |
|
| 2005 |
Shelton JG, Steelman LS, Abrams SL, Bertrand FE, Franklin RA, McMahon M, McCubrey JA. The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it? Expert Opinion On Therapeutic Targets. 9: 1009-30. PMID 16185155 DOI: 10.1517/14728222.9.5.1009 |
0.357 |
|
| 2005 |
Chappell WH, Green TD, Spengeman JD, McCubrey JA, Akula SM, Bertrand FE. Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1. Cell Cycle (Georgetown, Tex.). 4: 1389-95. PMID 16096376 DOI: 10.4161/Cc.4.10.2028 |
0.5 |
|
| 2005 |
McCubrey JA, Bertrand FE. Upping the bid on engineered inducible cell death. Cancer Biology & Therapy. 4: 537. PMID 15970693 DOI: 10.4161/Cbt.4.5.1863 |
0.316 |
|
| 2005 |
Shelton JG, Steelman LS, Abrams SL, White ER, Akula SM, Franklin RA, Bertrand FE, McMahon M, McCubrey JA. Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines. Cell Cycle (Georgetown, Tex.). 4: 822-30. PMID 15917660 DOI: 10.4161/Cc.4.6.1724 |
0.404 |
|
| 2005 |
Shelton JG, Steelman LS, Abrams SL, White ER, Akula SM, Bertrand FE, Franklin RA, McCubrey JA. Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line. Cell Cycle (Georgetown, Tex.). 4: 818-21. PMID 15908804 DOI: 10.4161/Cc.4.6.1723 |
0.441 |
|
| 2005 |
Spengeman JD, Green TD, McCubrey JA, Bertrand FE. Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells. Cell Cycle (Georgetown, Tex.). 4: 483-7. PMID 15701973 DOI: 10.4161/Cc.4.3.1533 |
0.479 |
|
| 2005 |
Bertrand FE, Spengemen JD, Shelton JG, McCubrey JA. Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support. Leukemia. 19: 98-102. PMID 15496972 DOI: 10.1038/Sj.Leu.2403560 |
0.468 |
|
| 2005 |
Libra M, Mazzarino MC, De Re V, Steelman LS, Abrams SL, Bertrand FE, Shelton JG, Molton S, McMahon M, McCubrey JA. Role of BRAF Mutations in Hematopoietic Malignancies and the Induction of Cytokine-Independence-Synergy with PI3K/Akt Pathway. Blood. 106: 4291-4291. DOI: 10.1182/Blood.V106.11.4291.4291 |
0.433 |
|
| 2005 |
Abrams SL, Steelman LS, Shelton JG, Chappell WH, Wong EW, Bertrand FE, McCubrey JA. Key Roles of the Raf-1 and Akt in Drug Resistance, Cell Cycle Progression and the Prevention of Apoptosis in Hematopoietic Cells. Blood. 106: 1356-1356. DOI: 10.1182/Blood.V106.11.1356.1356 |
0.404 |
|
| 2004 |
Steelman LS, Bertrand FE, McCubrey JA. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention. Expert Opinion On Therapeutic Targets. 8: 537-50. PMID 15584861 DOI: 10.1517/14728222.8.6.537 |
0.391 |
|
| 2004 |
Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 18: 189-218. PMID 14737178 DOI: 10.1038/Sj.Leu.2403241 |
0.445 |
|
| 2003 |
Bertrand FE, Spengeman JD, Shah N, LeBien TW. B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression Leukemia. 17: 2454-2459. PMID 14562113 DOI: 10.1038/Sj.Leu.2403178 |
0.436 |
|
| 2001 |
Bertrand FE, Vogtenhuber C, Shah N, LeBien TW. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein. Blood. 98: 3398-405. PMID 11719380 DOI: 10.1182/Blood.V98.12.3398 |
0.45 |
|
| 2001 |
Golub R, Martin D, Bertrand FE, Cascalho M, Wabl M, Wu GE. VH gene replacement in thymocytes. Journal of Immunology (Baltimore, Md. : 1950). 166: 855-60. PMID 11145660 DOI: 10.4049/Jimmunol.166.2.855 |
0.313 |
|
| 2000 |
Bertrand FE, Eckfeldt CE, Lysholm AS, LeBien TW. Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells. Leukemia. 14: 2095-102. PMID 11187898 DOI: 10.1038/Sj.Leu.2401942 |
0.456 |
|
| 2000 |
Bertrand FE, Eckfeldt CE, Fink JR, Lysholm AS, Pribyl JA, Shah N, LeBien TW. Microenvironmental influences on human B-cell development. Immunological Reviews. 175: 175-86. PMID 10933602 DOI: 10.1111/J.1600-065X.2000.Imr017513.X |
0.426 |
|
| 1997 |
Bertrand FE, Billips LG, Burrows PD, Gartland GL, Kubagawa H, Schroeder HW. Ig DH Gene Segment Transcription and Rearrangement Before Surface Expression of the Pan-B–Cell Marker CD19 in Normal Human Bone Marrow Blood. 90: 736-744. DOI: 10.1182/Blood.V90.2.736.736_736_744 |
0.346 |
|
| 1995 |
Billips LG, Nuñez CA, Bertrand FE, Stankovic AK, Gartland GL, Burrows PD, Cooper MD. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. The Journal of Experimental Medicine. 182: 973-82. PMID 7561700 DOI: 10.1084/Jem.182.4.973 |
0.382 |
|
| 1995 |
Bertrand FE, Billips LG, Schroeder HW. Analysis of DHQ52 gene segment transcription and rearrangement during B-cell development in human fetal bone marrow. Annals of the New York Academy of Sciences. 764: 228-30. PMID 7486529 DOI: 10.1111/J.1749-6632.1995.Tb55832.X |
0.345 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1998 |
Fanning L, Bertrand FE, Steinberg C, Wu GE. Molecular mechanisms involved in receptor editing at the Ig heavy chain locus International Immunology. 10: 241-246. PMID 9533453 DOI: 10.1093/Intimm/10.2.241 |
0.298 |
|
| 2011 |
Bertrand FE, Hewan-Lowe K, Catrou P, Angus CW, Sigounas G, Kellogg A. Abstract 3640: Potential cooperation of monoclonal antibody based targeting of gamma-glutamyl transferase (GGT1) with chemotherapy in kidney tumor xenografts Cancer Research. 71: 3640-3640. DOI: 10.1158/1538-7445.Am2011-3640 |
0.292 |
|
| 1995 |
Schroeder HW, Mortari F, Shiokawa S, Kirkham PM, Elgavish RA, Bertrand FE. Developmental regulation of the human antibody repertoire. Annals of the New York Academy of Sciences. 764: 242-60. PMID 7486531 DOI: 10.1111/J.1749-6632.1995.Tb55834.X |
0.286 |
|
| 2024 |
George DC, Bertrand FE, Sigounas G. Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes. Advances in Biological Regulation. 91: 101013. PMID 38290285 DOI: 10.1016/j.jbior.2024.101013 |
0.278 |
|
| 2010 |
Lu JQ, Ding H, Reynolds CL, Feng Y, Yang LV, Bertrand FE, McConnell TJ, Hu X. Angle-resolved Light Scattering Study of NALM-6 and HL-60 Cells for White Blood Cell Differentiation Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2010.Btud85 |
0.276 |
|
| 2007 |
Ojeda JF, Xie C, Li YQ, Bertrand FE, Wiley J, McConnell TJ. Chromosomal analysis and identification based on optical tweezers and Raman spectroscopy: reply. Optics Express. 15: 6000-2. PMID 19546903 DOI: 10.1364/Oe.15.006000 |
0.249 |
|
| 2011 |
Dong K, Feng Y, Jacobs KM, Lu JQ, Brock RS, Yang LV, Bertrand FE, Farwell MA, Hu XH. Label-free classification of cultured cells through diffraction imaging. Biomedical Optics Express. 2: 1717-26. PMID 21698031 DOI: 10.1364/Boe.2.001717 |
0.238 |
|
| 2006 |
Ojeda JF, Xie C, Li Y, Bertrand FE, Wiley J, McConnell TJ. Discrimination of Single Human Chromosomes Using Confocal Raman-Tweezers Spectroscopy Biosilico. DOI: 10.1364/Bio.2006.Tuf2 |
0.216 |
|
| 2003 |
Larson RA, Daley GQ, Schiffer CA, Porcu P, Pui CH, Marie JP, Steelman LS, Bertrand FE, McCubrey JA. Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002 Leukemia. 17: 2358-2382. PMID 14562120 DOI: 10.1038/sj.leu.2403156 |
0.21 |
|
| 2005 |
Bertrand FE, McCubrey JA. Acquired immunodeficiency syndrome associated lymphoma. Frontiers in Bioscience : a Journal and Virtual Library. 10: 2972-7. PMID 15970551 DOI: 10.2741/1753 |
0.207 |
|
| 1997 |
Bertrand FE, Billips LG, Burrows PD, Gartland GL, Kubagawa H, Schroeder HW. Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow Blood. 90: 736-744. PMID 9226174 |
0.206 |
|
| 1998 |
Bertrand FE, Golub R, Wu GE. V(H) gene replacement occurs in the spleen and bone marrow of non-autoimmune quasi-monoclonal mice European Journal of Immunology. 28: 3362-3370. PMID 9808206 DOI: 10.1002/(SICI)1521-4141(199810)28:10<3362::AID-IMMU3362>3.0.CO;2-8 |
0.164 |
|
| 2006 |
Ojeda JF, Xie C, Li YQ, Bertrand FE, Wiley J, McConnell TJ. Chromosomal analysis and identification based on optical tweezers and Raman spectroscopy. Optics Express. 14: 5385-93. PMID 19516705 |
0.07 |
|
| 1974 |
Bertrand FE. Nuclear Data Sheets for A = 106 Nuclear Data Sheets. 13. DOI: 10.1016/S0090-3752(74)80009-8 |
0.067 |
|
| 2023 |
Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen YH, Bertrand F, Gower B, Azziz R. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism. PMID 37329216 DOI: 10.1210/clinem/dgad356 |
0.052 |
|
| 1990 |
Jeandel C, Aymard J, Penin F, Bertrand F, George M, Cuny G. Syndrome 5 q-, dysgammaglobulinémie et déficit en alpha 1 antitrypsine (phénotype Pi ZZ) La Revue De MéDecine Interne. 11: S144. DOI: 10.1016/S0248-8663(05)82046-6 |
0.051 |
|
| 1968 |
Bertrand FE. A four parameter E vs dE/dx and time-of-flight computerized charged particle experiment Ieee Transactions On Nuclear Science. 15: 145-149. DOI: 10.1109/TNS.1968.4324845 |
0.049 |
|
| 1971 |
Bertrand F, Raman S. Nuclear data sheets for A = 110 Nuclear Data Sheets. 5: 487-530. DOI: 10.1016/S0090-3752(71)80052-2 |
0.046 |
|
| 2007 |
Ojeda JF, Xie C, Li YQ, Bertrand FE, Wiley J, McConnell TJ. Chromosomal analysis and identification based on optical tweezers and Raman spectroscopy: Reply Optics Express. 15: 6000-6002. DOI: 10.1364/OE.15.006000 |
0.044 |
|
| 1975 |
Urone PP, Bertrand FE. Nuclear data sheets for A = 78 Nuclear Data Sheets. 15: 107-136. DOI: 10.1016/S0090-3752(75)80034-2 |
0.043 |
|
| 2020 |
Bertrand FE, Slovensky DJ. Crafting a Team-Based, Interprofessional Undergraduate Research Honors Curriculum in the Health Professions. Journal of Allied Health. 49: e57-e62. PMID 32128550 |
0.02 |
|
| 1966 |
Bertrand FE, Peelle RW, Love TA, Fox RJ, Hill NW, Todd HA. A total-absorption detector for 60-mev protons using lithium-drifted germanium Ieee Transactions On Nuclear Science. 279-284. DOI: 10.1109/TNS.1966.4324110 |
0.02 |
|
| 1972 |
Bertrand FE, Burrus WR, Hill NW, Love TA, Peelle RW. A high resolution spectrometer system with particle identification for 1 through 60 MeV hydrogen and helium particles Nuclear Instruments and Methods. 101: 475-492. DOI: 10.1016/0029-554X(72)90034-1 |
0.01 |
|
| Hide low-probability matches. |